NASDAQ:DRIO - DarioHealth Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.72 +0.07 (+10.77 %) (As of 03/22/2019 12:03 PM ET)Previous Close$0.6501Today's Range$0.66 - $0.7252-Week Range$0.58 - $2.15Volume72,319 shsAverage Volume44,431 shsMarket Capitalization$24.16 millionP/E RatioN/ADividend YieldN/ABeta-1.29 ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications, and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy and distributors; and through e-stores. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel. Receive DRIO News and Ratings via Email Sign-up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DRIO Previous Symbol CUSIPN/A CIKN/A Webwww.mydario.com Phone972-4770-4055Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.19Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.17 million Price / Sales4.67 Cash FlowN/A Price / Cash FlowN/A Book Value$0.28 per share Price / Book2.57Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-15,740,000.00 Net Margins-343.72% Return on Equity-386.47% Return on Assets-255.38%Miscellaneous EmployeesN/A Outstanding Shares33,560,000Market Cap$24.16 million Next Earnings Date3/25/2019 (Confirmed) OptionableNot Optionable DarioHealth (NASDAQ:DRIO) Frequently Asked Questions What is DarioHealth's stock symbol? DarioHealth trades on the NASDAQ under the ticker symbol "DRIO." How were DarioHealth's earnings last quarter? DarioHealth Corp (NASDAQ:DRIO) issued its quarterly earnings results on Thursday, August, 9th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.18) by $0.14. The business earned $2.06 million during the quarter. DarioHealth had a negative net margin of 343.72% and a negative return on equity of 386.47%. View DarioHealth's Earnings History. When is DarioHealth's next earnings date? DarioHealth is scheduled to release their next quarterly earnings announcement on Monday, March 25th 2019. View Earnings Estimates for DarioHealth. What is the consensus analysts' recommendation for DarioHealth? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DarioHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for DarioHealth. Has DarioHealth been receiving favorable news coverage? Media headlines about DRIO stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. DarioHealth earned a coverage optimism score of 0.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of DarioHealth's key competitors? Some companies that are related to DarioHealth include STRATA Skin Sciences (SSKN), Apollo Endosurgery (APEN), Endologix (ELGX), iCAD (ICAD), CAS Medical Systems (CASM), Invo Bioscience (IVOB), Titan Medical (TMDI), Spectral Medical (EDTXF), Arch Therapeutics (ARTH), Motus GI (MOTS), Pro-Dex (PDEX), Repro-Med Systems (REPR), RA Medical Systems (RMED), AIT Therapeutics (AITB) and Obalon Therapeutics (OBLN). What other stocks do shareholders of DarioHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other DarioHealth investors own include AEterna Zentaris (AEZS), CorMedix (CRMD), Neurocrine Biosciences (NBIX), MEI Pharma (MEIP), Exelixis (EXEL), Galmed Pharmaceuticals (GLMD), Global Blood Therapeutics (GBT), Allergan (AGN), Novo Nordisk A/S (NVO) and Teva Pharmaceutical Industries (TEVA). Who are DarioHealth's key executives? DarioHealth's management team includes the folowing people: Mr. Erez Raphael, CEO & Director (Age 46)Mr. Zvi Ben David, CFO, Treasurer & Sec. (Age 58)Mr. Dror Bacher, Chief Operating Officer (Age 44)Mr. Olivier R. Jarry, Pres & Chief Commercial Officer (Age 58)Ms. Joao Mendes-Roter, VP of Marketing Who are DarioHealth's major shareholders? DarioHealth's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (9.99%) and BlackRock Inc. (0.12%). Company insiders that own DarioHealth stock include Allen Kamer, Erez Raphael, Hila Karah, Yoav Shaked and Zvi Ben-David. View Institutional Ownership Trends for DarioHealth. Which major investors are buying DarioHealth stock? DRIO stock was purchased by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC and BlackRock Inc.. Company insiders that have bought DarioHealth stock in the last two years include Allen Kamer, Erez Raphael, Hila Karah, Yoav Shaked and Zvi Ben-David. View Insider Buying and Selling for DarioHealth. How do I buy shares of DarioHealth? Shares of DRIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is DarioHealth's stock price today? One share of DRIO stock can currently be purchased for approximately $0.72. How big of a company is DarioHealth? DarioHealth has a market capitalization of $24.16 million and generates $5.17 million in revenue each year. What is DarioHealth's official website? The official website for DarioHealth is http://www.mydario.com. How can I contact DarioHealth? DarioHealth's mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The company can be reached via phone at 972-4770-4055 or via email at [email protected] MarketBeat Community Rating for DarioHealth (NASDAQ DRIO)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 163 (Vote Outperform)Underperform Votes: 142 (Vote Underperform)Total Votes: 305MarketBeat's community ratings are surveys of what our community members think about DarioHealth and other stocks. Vote "Outperform" if you believe DRIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRIO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What are no-load funds?